Innoveren Scientific Inc.
Innoveren Scientific Inc., a medical bioscience company that develops technology in regenerative medicine for limb salvage. It is also developing immunotherapies for ovarian cancer, pancreatic cancer, and mesothelioma. The company was formerly known as H-CYTE, Inc. and changed its name to Innoveren Scientific Inc. in July 2023. The company is headquartered in Tampa, Florida.
Innoveren Scientific Inc. (IVRN) - Total Assets
Latest total assets as of September 2023: $789.32K USD
Based on the latest financial reports, Innoveren Scientific Inc. (IVRN) holds total assets worth $789.32K USD as of September 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Innoveren Scientific Inc. - Total Assets Trend (2019–2022)
This chart illustrates how Innoveren Scientific Inc.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Innoveren Scientific Inc. - Asset Composition Analysis
Current Asset Composition (December 2022)
Innoveren Scientific Inc.'s total assets of $789.32K consist of 61.0% current assets and 39.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0.0% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2019–2022)
This chart illustrates how Innoveren Scientific Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Innoveren Scientific Inc.'s current assets represent 61.0% of total assets in 2022, a decrease from 69.6% in 2019.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2022, down from 43.5% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2019.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
Innoveren Scientific Inc. Competitors by Total Assets
Key competitors of Innoveren Scientific Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Innoveren Scientific Inc. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Innoveren Scientific Inc. generates 3.30x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Innoveren Scientific Inc. is currently not profitable relative to its asset base.
Innoveren Scientific Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.08 | 0.03 | 0.04 |
| Quick Ratio | 0.08 | 0.03 | 0.04 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-8.91 Million | $ -6.52 Million | $ -4.95 Million |
Innoveren Scientific Inc. - Advanced Valuation Insights
This section examines the relationship between Innoveren Scientific Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -57.3% |
| Total Assets | $137.36K |
| Market Capitalization | $130.13 USD |
Valuation Analysis
Below Book Valuation: The market values Innoveren Scientific Inc.'s assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Innoveren Scientific Inc.'s assets decreased by 57.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Innoveren Scientific Inc. (2019–2022)
The table below shows the annual total assets of Innoveren Scientific Inc. from 2019 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-12-31 | $137.36K | -57.26% |
| 2021-12-31 | $321.40K | -85.42% |
| 2020-12-31 | $2.20 Million | -32.61% |
| 2019-12-31 | $3.27 Million | -- |